|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
3/31/22 An Chihliang 3 Officer² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
12/10/21 Sakamoto Norimi 3 Director² 1:3K Abvc Biopharma, Inc. EdgarAgents LLC/FA
12/10/21 Odaira Yoshinobu 3 Director² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/15/21 Jiang Tsung Shann 3 Dir.,Off.² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/15/21 Miao Shin-Yu 3 Director² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/15/21 Jiang Eugene 3 Dir.,Off.² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/15/21 Jiang Chang-Jen 3 Director² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/5/21 King Chi-Hsin Richard 3 Officer² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/5/21 Chou Yen-Hsin 3 Director² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
11/5/21 Doong Howard 3 Officer² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
10/26/21 Jiang Tsang Ming 3 Director² 1:4K Abvc Biopharma, Inc. EdgarAgents LLC/FA
8/2/21‡ Abvc Biopharma, Inc. EFFECT 8/2/21 1:2K SEC #5
8/2/21 Abvc Biopharma, Inc. CERT 8/2/21 1:971K Nasdaq Stock Market LLC
8/2/21 Abvc Biopharma, Inc. 8-A12B 1:14K EdgarAgents LLC/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Types: -K | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 8-A12B | Registration Statement for a Class of Securities — Form 8-A. | | CERT | Certification by a Securities Exchange Approving a Listing — Form CERT. | | EFFECT | SEC Notice of Effectiveness. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|